Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

Charlotte FM Hughes; Amit Khot; Christopher McCormack; Stephen Lade; David Westerman; Robert Twigger; Odette Buelens; Kate Newland; Constantine S. Tam; Michael Dickinson; Gail Ryan; David Ritchie; Colin Wood; H. Miles Prince

doi:10.1182/blood-2014-07-588236

Related publications

Article2020

Mycosis fungoides and Sézary syndrome: Australian clinical practice statement

Friyana Bhabha, Christopher McCormack, Jillian Wells, Belinda A. Campbell, Kate Newland, Stephen Lade, Odette Buelens, David Joske, Jake Shortt, Sally Mapp, Dejan Radeski, Mark Hertzberg, Amit Khot, Carrie Van Der Weyden, Christine Khoo, Eliza A. Hawkes, H. Miles Prince

Article2023

Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome

Ilana Levy Yurkovski, Lior Rokach, Guy Melamed, Hillel Alapi, Sivan Gazit, Tal Patalon, Tamar Tadmor

Acta Haematologica

Letter2022

Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides

Jessica Elliott, Shalini Ahlawat, H. Miles Prince, Glen Kennedy, Jillian Wells, Gillian Huang, Jenny Collins, Peter Bardy, Carrie Van Der Weyden, David Ritchie, Amit Khot

Article2023

P1532: CLINICAL OUTCOMES OF COVID-19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)

Ilana Levy, Lior Rokach, Guy Melamed, Hilel Alapi, Sivan Gazit, Tal Patalon, Tamar Tadmor

HemaSphere

Article2019

Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study

Youn H. Kim, M. Bagot, Pier Luigi Zinzani, Madeleine Duvic, Stephen Morris, Ellen Kim, Amy Musiek, Pablo L. Ortiz‐Romero, Craig A. Elmets, Herbert Eradat, Nina Magnolo, Julia Scarisbrick, Stéphane Dalle, David C. Fisher, Michi M. Shinohara, Brian Poligone, Barbara Pro, Pietro Quaglino, Nishitha Reddy, Brigitte Dréno, Larisa J. Geskin, Ahmad Halwani, Amit Khot,